273 research outputs found
Effects of shadowing on Drell-Yan dilepton production in high energy nuclear collisions
We compute cross sections for the Drell-Yan process in nuclear collisions at
next-to-leading order (NLO) in \alpha_s. The effects of shadowing on the
normalization and on the mass and rapidity dependence of these cross sections
are presented. An estimate of higher order corrections is obtained from
next-to-next-to-leading order (NNLO) calculation of the rapidity-integrated
mass distribution. Variations in these predictions resulting from choices of
parton distribution sets are discussed. Numerical results for mass
distributions at NLO are presented for RHIC and LHC energies, using appropriate
rapidity intervals. The shadowing factors in the dilepton mass range 2 < M < 10
GeV are predicted to be substantial, typically 0.5 - 0.7 at LHC, 0.7 - 0.9 at
RHIC, and approximately independent of the choice of parton distribution sets
and the order of calculation.Comment: 13 pages, 9 eps figure
Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation
Perfusion and oxygenation of experimental tumours were studied during angiotensin II (AT II) administration whereby the rate of the continuous AT II infusion was chosen to increase the mean arterial blood pressure (MABP) by 50â70 mmHg. In subcutaneous DS- sarcomas the red blood cell (RBC) flux was assessed using the laser Doppler technique and the mean tumour oxygen partial pressure (p O 2) was measured polarographically using O 2-sensitive catheter and needle electrodes. Changes in RBC flux with increasing MABP depended mainly on tumour size. In small tumours, RBC flux decreased with rising MABP whereas in larger tumours RBC flux increased parallel to the MABP. As a result of these volume-dependent effects on tumour blood flow, the impact of AT II on tumour p O 2 was also mainly tumour volume-related. In small tumours oxygenation decreased with increasing MABP during AT II infusion, whereas in large tumours a positive relationship between blood pressure and O 2 status was found. This disparate behaviour might be the result of the co-existence of two functionally distinct populations of tumour vessels. In small tumours, perfusion decreases presumably due to vasoconstriction of pre-existing host vessels feeding the tumour. In larger malignancies, newly formed tumour vessels predominate and seem not to have this vasoresponsive capability (lack of smooth muscle cells and/or AT receptors), resulting in an improvement of perfusion which is not tumour-related per se, but is due to the increased perfusion pressure. © 2000 Cancer Research Campaig
Evidence for charmonium generation at the phase boundary in ultra-relativistic nuclear collisions
We investigate the transition from suppression to enhancement of J/psi mesons
produced in ultra-relativistic nuclear collisions in the framework of the
statistical hadronization model. The calculations are confronted with the most
recent data from the RHIC accelerator. This comparison yields first direct
evidence for generation of J/psi mesons at the phase boundary. Based on the
success of this approach we make specific predictions for LHC energy.Comment: 5 pages, 2 figures; final version accepted for publication in Phys.
Lett. B (Fig.1 containd a new set of calculations
B_c Meson Production in Nuclear Collisions at RHIC
We study quantitatively the formation and evolution of B_c bound states in a
space-time domain of deconfined quarks and gluons (quark-gluon plasma, QGP). At
the Relativistic Heavy Ion Collider (RHIC) one expects for the first time that
typical central collisions will result in multiple pairs of heavy (in this case
charmed) quarks. This provides a new mechanism for the formation of heavy
quarkonia which depends on the properties of the deconfined region. We find
typical enhancements of about 500 fold for the B_c production yields over
expectations from the elementary coherent hadronic B_c-meson production
scenario. The final population of bound states may serve as a probe of the
plasma phase parameters.Comment: 9 Pages, 11 Postscript Figure
An Experimental Overview of Results Presented at SQM 2006
I have been asked to give an critical overview on the experimental results
shown in the conference with a emphasis of what has been learned and the
challenges that are ahead in trying to understand the physics of the strongly
interacting quark-gluon plasma. I will not try to summarize all of the results
presented, rather I will concentrate primarily on RHIC data from this
conference. Throughout this summary, I will periodically review some of the
previous results for those not familiar with the present state of the field.Comment: 15 pages, 12 Figure
Statistical hadronization of charm at SPS, RHIC and LHC
We study the production of charmonia and charmed hadrons for nucleus-nucleus
collisions at SPS, RHIC, and LHC energies within the framework of the
statistical hadronization model. Results from this model are compared to the
observed centrality dependence of J/psi production at SPS energy. We further
provide predictions for the centrality dependence of the production of open and
hidden charm mesons at RHIC and LHC.Comment: Contribution to Quark Matter 2002, 4 pages, 3 figures; revised
version including charmed hyperons (omitted in v1
PRODUCTION OF DRELL--YAN PAIRS IN HIGH ENERGY NUCLEON--NUCLEON COLLISIONS
We compute cross sections for the Drell-Yan process in N--N collisions at
next-to-leading order in . The mass, rapidity, transverse momentum,
and angular dependence of these cross sections are presented. An estimate of
higher order corrections is obtained from next-to-next-to-leading order
calculation of the mass distribution. We compare the results with some of the
existing data to show the quality of the agreement between calculations and
data. We present predictions for energies which will become available at the
RHIC and LHC colliders. Uncertainties in these predictions due to choices of
scale, scheme and parton distribution are discussed.Comment: 27 pages (latex) plus 28 postscript figure
- âŠ